Insmed Inc Stock Performance
| INSM Stock | USD 159.03 5.88 3.57% |
The company retains a Market Volatility (i.e., Beta) of -0.0251, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Insmed are expected to decrease at a much lower rate. During the bear market, Insmed is likely to outperform the market. At this point, Insmed Inc has a negative expected return of -0.38%. Please make sure to check out Insmed's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Insmed Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Insmed Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (3.57) | Five Day Return 6.08 | Year To Date Return (10.21) | Ten Year Return 1.2 K | All Time Return (3.62) |
Last Split Factor 1:10 | Last Split Date 2011-03-03 |
1 | Disposition of 5000 shares by Anderson Elizabeth M of Insmed at 204.58 subject to Rule 16b-3 | 11/24/2025 |
2 | Disposition of 8895 shares by Flammer Martina M.d. of Insmed at 25.83 subject to Rule 16b-3 | 12/01/2025 |
3 | Insmed Stock News Today Nasdaq100 Addition, Brensocatib Setback, and Updated Analyst Forecasts - ts2.tech | 12/22/2025 |
4 | INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM | 01/08/2026 |
5 | Disposition of 447 shares by Lewis William of Insmed at 164.24 subject to Rule 16b-3 | 01/16/2026 |
6 | Disposition of 4440 shares by Lewis William of Insmed at 17.16 subject to Rule 16b-3 | 01/20/2026 |
7 | Disposition of 7982 shares by Flammer Martina M.d. of Insmed at 65.72 subject to Rule 16b-3 | 02/02/2026 |
8 | Disposition of 795 shares by Flammer Martina M.d. of Insmed at 155.77 subject to Rule 16b-3 | 02/03/2026 |
9 | Insider Selling Insmed CEO Sells 3,009 Shares of Stock | 02/04/2026 |
10 | Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026 | 02/05/2026 |
11 | Is It Time To Reassess Insmed After The Recent Share Price Pullback | 02/11/2026 |
12 | Insmed To Present at March 2026 Investor Conferences | 02/13/2026 |
13 | 1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today | 02/17/2026 |
14 | Insmed Q4 Earnings Call Highlights | 02/19/2026 |
15 | Insmed Incorporated Q4 2025 Earnings Call Transcript | 02/20/2026 |
| Begin Period Cash Flow | 555 M | |
| Total Cashflows From Investing Activities | -64.6 M | |
| Free Cash Flow | -967.6 M |
Insmed Relative Risk vs. Return Landscape
If you would invest 20,451 in Insmed Inc on November 26, 2025 and sell it today you would lose (4,548) from holding Insmed Inc or give up 22.24% of portfolio value over 90 days. Insmed Inc is currently does not generate positive expected returns and assumes 3.0371% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than Insmed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Insmed Target Price Odds to finish over Current Price
The tendency of Insmed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 159.03 | 90 days | 159.03 | about 79.23 |
Based on a normal probability distribution, the odds of Insmed to move above the current price in 90 days from now is about 79.23 (This Insmed Inc probability density function shows the probability of Insmed Stock to fall within a particular range of prices over 90 days) .
Insmed Price Density |
| Price |
Predictive Modules for Insmed
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Insmed Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Insmed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Insmed Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Insmed is not an exception. The market had few large corrections towards the Insmed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Insmed Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Insmed within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.29 | |
β | Beta against Dow Jones | -0.03 | |
σ | Overall volatility | 20.41 | |
Ir | Information ratio | -0.12 |
Insmed Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Insmed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Insmed Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Insmed Inc generated a negative expected return over the last 90 days | |
| Insmed Inc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 606.42 M. Net Loss for the year was (1.28 B) with profit before overhead, payroll, taxes, and interest of 483.48 M. | |
| Insmed Inc currently holds about 554.87 M in cash with (935.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62. | |
| Insmed Inc has a frail financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from massdevice.com: ProSomnus raises 38M for CPAP alternative |
Insmed Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Insmed Stock often depends not only on the future outlook of the current and potential Insmed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Insmed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 213.6 M | |
| Cash And Short Term Investments | 1.4 B |
Insmed Fundamentals Growth
Insmed Stock prices reflect investors' perceptions of the future prospects and financial health of Insmed, and Insmed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insmed Stock performance.
| Return On Equity | -2.49 | ||||
| Return On Asset | -0.29 | ||||
| Profit Margin | (2.11) % | ||||
| Operating Margin | (0.95) % | ||||
| Current Valuation | 31.02 B | ||||
| Shares Outstanding | 213.27 M | ||||
| Price To Earning | (8.70) X | ||||
| Price To Book | 25.84 X | ||||
| Price To Sales | 55.93 X | ||||
| Revenue | 606.42 M | ||||
| Gross Profit | 483.48 M | ||||
| EBITDA | (1.12 B) | ||||
| Net Income | (1.28 B) | ||||
| Cash And Equivalents | 554.87 M | ||||
| Cash Per Share | 4.62 X | ||||
| Total Debt | 45.71 M | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | 3.45 X | ||||
| Cash Flow From Operations | (935.01 M) | ||||
| Earnings Per Share | (6.18) X | ||||
| Market Capitalization | 33.92 B | ||||
| Total Asset | 2.26 B | ||||
| Retained Earnings | (5.64 B) | ||||
| Working Capital | 1.32 B | ||||
| Current Asset | 28.15 M | ||||
| Current Liabilities | 3.89 M | ||||
About Insmed Performance
By examining Insmed's fundamental ratios, stakeholders can obtain critical insights into Insmed's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Insmed is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 386.02 | 533.76 | |
| Return On Tangible Assets | (0.63) | (0.66) | |
| Return On Capital Employed | (0.66) | (0.62) | |
| Return On Assets | (0.56) | (0.59) | |
| Return On Equity | (1.73) | (1.81) |
Things to note about Insmed Inc performance evaluation
Checking the ongoing alerts about Insmed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insmed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Insmed Inc generated a negative expected return over the last 90 days | |
| Insmed Inc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 606.42 M. Net Loss for the year was (1.28 B) with profit before overhead, payroll, taxes, and interest of 483.48 M. | |
| Insmed Inc currently holds about 554.87 M in cash with (935.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62. | |
| Insmed Inc has a frail financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from massdevice.com: ProSomnus raises 38M for CPAP alternative |
- Analyzing Insmed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insmed's stock is overvalued or undervalued compared to its peers.
- Examining Insmed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Insmed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insmed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Insmed's stock. These opinions can provide insight into Insmed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Will Biotechnology sector continue expanding? Could Insmed diversify its offerings? Factors like these will boost the valuation of Insmed. Market participants price Insmed higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (6.18) | Revenue Per Share | Quarterly Revenue Growth 1.526 | Return On Assets | Return On Equity |
Investors evaluate Insmed Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Insmed's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Insmed's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Insmed's market price signifies the transaction level at which participants voluntarily complete trades.